Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline ...

Donald Trump warned it was “not easy” to hold negotiations with China as trade talks in London entered a second day. The US ...

European shares closed little changed on Tuesday in cautious trade as investors awaited the outcome of the second day of U.S.

Bloomberg says Zuckerberg has prioritized recruiting for the new team, referred internally as a “superintelligence group.” He ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Novo Nordisk (NYSE:NVO) rose to its highest level in over two months Monday after a media report said hedge fund Parvus Asset ...

Novo Nordisk (NVO) shares hit their highest level in over two months following a Financial Times report that activist hedge ...

(Reuters) -European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

European stocks were steady on Tuesday, shrugging off modest losses from the previous session, as investors stayed on edge ...

--Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a new chief executive following a share-price slump, according to the ...

This update covers current health news, focusing on Parvus Asset Management's influence on Novo Nordisk's CEO selection, ...